Antroquinonol administration in animal preclinical studies for Alzheimer's disease (AD): A new avenue for modifying progression of AD pathophysiology

Despite the rise of Alzheimer's disease (AD) in an ageing population, no cure is currently available for this disorder. This study assessed the role of a natural compound, Antroquinonol, in modifying the progression of AD when administered at the start and/or before appearance of symptoms and w...

Descripción completa

Detalles Bibliográficos
Autores principales: Francesca, Fernandez, Caitlin, Aust, Sarah, Lye, Robyn, Griffiths Lyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892093/
https://www.ncbi.nlm.nih.gov/pubmed/35252893
http://dx.doi.org/10.1016/j.bbih.2022.100435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892093/
https://www.ncbi.nlm.nih.gov/pubmed/35252893
http://dx.doi.org/10.1016/j.bbih.2022.100435

Ejemplares similares